UroGen Pharma’s latest analyst update keeps the fair value target effectively anchored at US$35.63, with no reset in the central valuation estimate. Bullish voices see this as support for a ...
Medicines can stop pain, fight cancer and save lives but are worthless if they get lost in the mail, spoil in a hot warehouse ...
BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION 1. The Secretary of Commerce (Secretary) recently transmitted to me a report on his ...
Datapharm, the provider of the electronic medicines compendium (emc, medicines.org.uk), today announced its new partnership ...
Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, ...
Morning Overview on MSN
EPA adds microplastics, pharmaceuticals to drinking water watch list
The Environmental Protection Agency on April 2, 2026, placed microplastics and pharmaceuticals on its drinking water watch ...
In connection with the Chapter 11 cases, the Company expects to seek customary “first-day” relief that, if approved by the Court, would allow it to continue day-to-day operations, including ...
The company says using AI cuts years off of research time.
More than 60% average improvement in clitoral blood flow observed with both dose-combinations . Statistical significance achieved with new high dos ...
KLEA HOLDING - Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals ...
The Environmental Protection Agency proposed Thursday to include microplastics and pharmaceuticals on a list of contaminants ...
Arletta Pharma announces positive results from phase II CDU study of Lybrido combination targeting female sexual dysfunction: Amsterdam, the Netherlands Monday, March 30, 2026, 16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results